Welcome to the new Actavis, Inc., the powerful combination of Watson Pharmaceuticals, Inc. and the Actavis Group. As a result of this historic combination, we have transformed our company into the third largest generic pharmaceutical company in the world.

Today, we provide trusted generic, branded generic and specialty pharmaceutical products in more than 60 countries around the world, with the potential to reach more than 5 billion of the world’s consumers. And we are aggressively building a leading position in providing biosimilar versions of biopharmaceutical products in the coming years.

With our expansion into more than 60 commercial markets around the world, we recognized the many benefits of uniting our Company under one name to all stakeholders – customers, consumers, payers, institutions and shareholders and potential shareholders. Our new name, Actavis, Inc., and our new logo, captures the exciting potential of our new company.

We are proud of our new name and our new logo. The distinctive redesign of the Actavis name reflects the history of both Watson and Actavis.

Our new icon speaks to our Company’s fast-evolving business, as well as its dynamic culture. A close look reveals a “W” shape emerging from a shaded “A”, a subtle historical reference to the Watson heritage and acquisition of Actavis.

Our new color stands out in the universe of pharmaceutical industry competitors and reflects growth — a fundamental foundation for our Company and its future. The result is a new, powerful and accessible visualization that celebrates our Company’s emergence as a global pharmaceutical leader, and visually defines our focus on growth and success in the future.

Trading under a new symbol – ACT – on the New York Stock Exchange (NYSE), Actavis is committed to leadership in R&D, quality and customer service. We are committed to creating even more value for our customers and our shareholders.

Welcome to the new Actavis, Inc. We are just getting started.